Bilal Hasdemir

Bilal Hasdemir

Live and Feel Content Team
...
Views
Read Time
Rare Genetic Results Double Sickle Cell Risk
Rare Genetic Results Double Sickle Cell Risk 4

Preventing sickle cell disease in pregnancy is very important for moms-to-be and doctors. Sickle cell disease is a blood disorder passed down through families. It can cause serious problems, even more so during pregnancy.

Every year, over 300,000 newborns worldwide are born with sickle cell disease. This makes preconception genetic counseling and screening very important. By understanding the risks and taking action early, families can lessen the effects of this disorder.

Key Takeaways

  • Preconception genetic counseling is key to preventing sickle cell disease in pregnancy.
  • Sickle cell disease affects hundreds of thousands of newborns worldwide each year.
  • Genetic testing can spot carriers of the sickle cell gene, helping with family planning.
  • There are advanced reproductive options for families at risk of passing on sickle cell disease.
  • Getting care from a team of experts is vital for managing sickle cell disease during pregnancy.

Understanding Sickle Cell Disease: A Genetic Overview

It’s important to know the genetic roots of sickle cell disease to manage it well. Sickle cell disease (SCD) is a group of genetic disorders. They affect how red blood cells make hemoglobin.

What is Sickle Cell Disease?

Sickle cell disease arises from an abnormal hemoglobin known as hemoglobin S.” — This abnormal hemoglobin makes red blood cells bend into a sickle shape. This shape leads to early destruction of the cells and health problems.

SCD is an autosomal recessive disorder. This means both parents must carry the mutated gene for a child to have the disease. Carriers have one normal and one mutated gene. They usually don’t show all the symptoms but can pass the mutated gene to their kids.

The Genetic Basis of Sickle Cell Disease

The genetic cause of SCD is a mutation in the HBB gene. This gene codes for the beta-globin subunit of hemoglobin. The mutation leads to sickle hemoglobin production. The disease is inherited in an autosomal recessive pattern, needing two mutated copies to show symptoms.

The mutation in the HBB gene changes glutamic acid to valine at the sixth position of the beta-globin chain. This change causes sickle hemoglobin production. This genetic change is the main reason for the disease’s effects.

Types of Sickle Cell Disease

There are several types of SCD, mainly based on the genotype. The most common types include:

Type

Genotype

Description

HbSS

Homozygous for sickle hemoglobin

Most severe form, characterized by frequent vaso-occlusive crises.

HbSC

Compound heterozygous for HbS and HbC

Milder than HbSS, but can cause significant health issues.

HbSβ-Thalassemia

Compound heterozygous for HbS and β-thalassemia

Severity varies depending on the type of β-thalassemia mutation.

Knowing these types is key to managing the disease well. It helps in providing the right genetic counseling.

The Global Impact of Sickle Cell Disease

Rare Genetic Results Double Sickle Cell Risk
Rare Genetic Results Double Sickle Cell Risk 5

Sickle Cell Disease has a huge impact on public health worldwide. It’s a big problem in many places, but most in sub-Saharan Africa.

Prevalence and Distribution

Sickle Cell Disease is a common inherited disorder. It affects millions globally, mainly in Africa, the Mediterranean, and parts of Asia. It’s more common where malaria used to be common because it offers some protection.

It’s not just in these areas; it’s found worldwide because of migration and genetic mixing. In the U.S., about 100,000 people have it, with many more carriers.

Socioeconomic Burden

The cost of Sickle Cell Disease is huge. It includes medical costs, lost work, and effects on families and communities. People with SCD often need a lot of medical care and deal with chronic pain.

This burden is not just on individuals and families but also on healthcare systems and societies. In poor areas, lack of healthcare makes managing SCD even harder.

Annual Incidence of Affected Newborns

Every year, over 300,000 newborns are born with Sickle Cell Disease. This shows how big a public health issue it is. Early diagnosis and care are key to helping these children.

Newborn screening and good care can lessen the disease’s effects. Efforts to raise awareness and improve SCD management are vital to reduce its impact.

Inheritance Patterns: Is Sickle Cell Anemia Preventable?

Couples worried about sickle cell disease need to know how it’s inherited. This info helps them plan their family better.

Autosomal Recessive Inheritance

Sickle cell disease follows an autosomal recessive pattern. This means the gene causing the disease is on a non-sex chromosome. A person needs two copies of this gene, one from each parent, to have the disease.

Key characteristics of autosomal recessive inheritance include:

  • Affected individuals have two copies of the mutated gene.
  • Carriers have one normal and one mutated gene, typically not showing symptoms.
  • There’s a 25% chance with each pregnancy that the child will inherit two mutated genes (one from each carrier parent) and have the disease.

Carrier Status vs. Disease State

It’s important to know the difference between being a carrier and having sickle cell disease. Carriers have one normal and one sickle gene. They are usually healthy but can pass the sickle gene to their kids.

On the other hand, people with sickle cell disease have two sickle genes. This leads to abnormal hemoglobin and health problems.

Probability of Inheritance

Couples who carry the sickle cell gene have certain chances of passing it to their kids. With each pregnancy, there’s a:

  1. 25% chance the child will inherit two normal genes (not a carrier).
  2. 50% chance the child will inherit one normal and one sickle gene (carrier).
  3. 25% chance the child will inherit two sickle genes (has sickle cell disease).

Knowing these chances is key for genetic counseling and planning families.

Understanding sickle cell disease’s inheritance helps couples know their risks. They can then make choices about genetic testing and counseling for their family planning.

Rare Genetic Results: Double Sickle Cell and Its Implications

Rare genetic combinations, like double sickle cell, can greatly affect pregnancy outcomes. We will look into the genetic details behind these conditions and their importance in healthcare.

Understanding Homozygous vs. Heterozygous States

In sickle cell disease, people can be homozygous or heterozygous for the sickle cell gene. Homozygous individuals have two mutated genes, one from each parent, showing full sickle cell disease. Heterozygous individuals, or carriers, have one normal and one mutated gene. They don’t show the full disease but can pass the mutation to their kids.

“Knowing if someone is homozygous or heterozygous is key for genetic counseling,” say genetic counselors. It helps understand the risk of passing sickle cell disease to future generations.

Double Heterozygosity Explained

Double heterozygosity happens when someone gets two different mutated genes, one from each parent. This can cause different levels of disease, depending on the mutations.

In sickle cell disease, double heterozygosity might mean one sickle cell gene and another abnormal hemoglobin gene. The symptoms can range from mild to severe, needing close monitoring and care.

Clinical Significance in Pregnancy

The impact of rare genetic results, like double sickle cell, is big during pregnancy. These conditions can raise the risk of pregnancy problems, like pre-eclampsia and preterm labor.

A study shows, “Pregnancies in women with sickle cell disease are high-risk.” They need a team effort to reduce complications. So, healthcare providers must know the genetic status of pregnant women to give the right care.

We suggest that pregnant women with rare genetic conditions get full prenatal care. This includes regular check-ups and counseling to improve outcomes for both mom and baby.

Sickle Cell Genotypes and Their Clinical Significance

Different sickle cell genotypes bring unique challenges. Understanding these differences is key to proper care during pregnancy. Each genotype has its own set of clinical implications.

AS Genotype (Sickle Cell Trait)

The AS genotype, or sickle cell trait, is usually not symptomatic. Yet, it can have big implications during pregnancy. People with this genotype can pass the sickle cell gene to their children.

Key Considerations for AS Genotype:

  • Generally asymptomatic but may experience some complications
  • Increased risk of urinary tract infections
  • Possible implications for pregnancy outcomes

SS Genotype (Sickle Cell Anemia)

The SS genotype is linked to sickle cell anemia, a more severe form. This genotype can cause serious health issues. These include anemia, infections, and vaso-occlusive crises.

Clinical Implications of SS Genotype:

  • Severe anemia and related complications
  • Increased risk of infections and vaso-occlusive crises
  • Potential for significant pregnancy-related complications

Other Sickle Cell Genotypes

There are other sickle cell genotypes, like SC and Sβ-thalassemia. Each has its own clinical implications.

Genotype

Clinical Implications

AS

Generally asymptomatic, but possible increased risk of complications during pregnancy

SS

Severe anemia, infections, vaso-occlusive crises, and pregnancy complications

SC

Mild to moderate anemia, risk of vaso-occlusive crises

Sβ-thalassemia

Variable severity, potentially anemia and other complications

Implications for Pregnancy

The implications of these genotypes for pregnancy are significant. Pregnant individuals with sickle cell disease need careful monitoring. This is to mitigate risks to both mother and fetus.

We suggest a detailed approach to managing sickle cell disease during pregnancy. This includes regular prenatal care, monitoring for complications, and appropriate interventions as needed.

Sickle Cell Disease in Pregnancy: Maternal Risks

Sickle cell disease and pregnancy come together with unique challenges. Women with this disease face higher health risks during pregnancy. This makes it vital to have detailed care plans.

Increased Mortality Risk

Pregnant women with sickle cell disease are at a higher risk of death. This risk highlights the need for close monitoring and management during pregnancy.

Pregnancy Complications

Sickle cell disease can cause several pregnancy complications. These include anemia, infections, and acute chest syndrome. These issues can harm both the mother and the baby, making early intervention key.

Vaso-occlusive Crises During Pregnancy

Vaso-occlusive crises are common in sickle cell disease and can happen more often during pregnancy. These crises are due to increased metabolic demand and other changes. It’s important to manage pain effectively to lessen their impact.

Risk of Pre-eclampsia and Caesarean Delivery

Women with sickle cell disease are more likely to get pre-eclampsia. This condition is marked by high blood pressure and protein in the urine. It may lead to caesarean delivery, which also has risks.

Managing pre-eclampsia in these women requires a team effort. This is as per the.

By knowing these risks and using the right care, we can help pregnant women with sickle cell disease have better outcomes.

Fetal and Neonatal Risks in Sickle Cell Pregnancies

Pregnancies in women with sickle cell disease (SCD) carry big risks for the baby. SCD can cause health problems for both the mother and the baby.

Preterm Birth

One big risk is preterm birth. This means the baby is born before 37 weeks. Women with SCD are more likely to have preterm labor because of the disease’s effects.

Preterm birth can cause health issues for the baby. These include breathing problems, being underweight, and a higher chance of infections. We’ll look at these issues more closely below.

Low Birth Weight

Another risk is low birth weight. Babies of mothers with SCD often weigh less because of problems with the placenta and anemia. Low birth weight can lead to developmental delays and a higher risk of infections.

Other Adverse Neonatal Outcomes

SCD pregnancies also face other risks. These include:

  • Small for gestational age (SGA) babies
  • Neonatal intensive care unit (NICU) admissions
  • Increased risk of stilbirth

The table below shows some key risks for babies in SCD pregnancies.

Risk Factor

Description

Potential Complications

Preterm Birth

Birth before 37 weeks of gestation

Respiratory distress syndrome, low birth weight

Low Birth Weight

Baby weighs less than 2,500 grams

Developmental delays, increased infections

Small for Gestational Age (SGA)

Baby’s weight is below the 10th percentile

Increased risk of NICU admission

It’s important to understand these risks to manage SCD pregnancies well. Women with SCD should get good prenatal care. This includes regular check-ups and genetic counseling to reduce these risks.

Preconception Planning for Couples at Risk

For couples at risk, preconception planning is key. It helps them understand and lower the risks of sickle cell disease (SCD). This early stage is vital for spotting risks and taking steps to reduce them.

Identifying At-Risk Couples

Finding out if a couple is at risk of having a child with SCD is the first step. Genetic screening is a big part of this. It helps couples know their carrier status, guiding their reproductive choices.

Health Optimization Before Pregnancy

Before getting pregnant, women with SCD need to get their health in check. This means managing their SCD well, staying up-to-date with vaccines, and living a healthy lifestyle. Preconception care can greatly improve the chances of a healthy pregnancy.

Medication Considerations

Thinking about medications is also key in preconception planning. Some SCD meds might need to change or stop before pregnancy to protect the baby. Doctors and patients work together to adjust treatment plans safely.

Aspect

Description

Importance

Genetic Screening

Identifying carrier status for SCD

High

Health Optimization

Managing SCD, vaccinations, healthy lifestyle

High

Medication Adjustment

Adjusting medications to minimize fetal risks

High

By taking these steps, couples at risk can understand their choices better. They can make informed decisions about their reproductive health.

Genetic Counseling for Sickle Cell Disease

Genetic counseling helps people understand sickle cell disease risks. It’s key for those at risk, giving them the info to make smart choices about having kids.

When to Seek Genetic Counseling

If you or your partner might carry the sickle cell gene, get genetic counseling. It’s a must for those with SCD in their family or from certain ethnic groups. Early counseling can reveal risks and options.

What to Expect During Counseling

A healthcare pro will look at the chance of passing SCD to kids during counseling. They’ll talk about family history, genetic tests, and what the results mean. Counselors offer emotional support and explain complex genetic stuff, helping you decide.

Making Informed Reproductive Decisions

Genetic counseling lets couples make smart choices about having kids. They might choose prenatal tests, PGD with IVF, or adoption. Counselors help weigh the pros and cons of each, based on your values and health.

Ethical Considerations

Ethics are big in SCD genetic counseling. Counselors must share info carefully, respecting your beliefs. Respecting your choices is key, but also making sure you’re well-informed.

For more on SCD’s genetics, check out. It dives deep into the disease’s genetic roots.

Genetic Testing Options for Sickle Cell Anemia

Rare Genetic Results Double Sickle Cell Risk
Rare Genetic Results Double Sickle Cell Risk 6

Genetic testing is key in managing and preventing sickle cell anemia. With growing knowledge of the disease’s genetics, many testing options are now available. These help individuals and families at risk.

Carrier Screening Tests

Carrier screening tests find people who carry the sickle cell gene. They are vital for couples planning to have children. These tests check for the sickle cell trait through a simple blood test.

Benefits of Carrier Screening:

  • Early identification of carriers
  • Informed family planning decisions
  • Reduced risk of having a child with sickle cell anemia

Prenatal Diagnostic Tests

Prenatal tests diagnose sickle cell disease in the fetus during pregnancy. They give expectant parents vital information. This helps them prepare for a child with sickle cell anemia or make informed pregnancy decisions.

The two main prenatal diagnostic tests are:

  • Chorionic Villus Sampling (CVS)
  • Amniocentesis

Test

Description

Timing

CVS

Sampling of placental tissue

10-12 weeks

Amniocentesis

Sampling of amniotic fluid

15-20 weeks

Non-invasive Prenatal Testing

Non-invasive prenatal testing (NIPT) is a new technology. It detects cell-free fetal DNA in the mother’s blood. While mainly for chromosomal abnormalities, some NIPT tests can find sickle cell disease.

NIPT is a big step forward in prenatal care. It’s safer than invasive tests. But, it’s important to know its limits and accuracy for sickle cell disease.

As genetic testing technology improves, more options for diagnosing and managing sickle cell anemia will emerge. This will give families and healthcare providers more choices.

Advanced Reproductive Technologies for Prevention

Advanced reproductive technologies have changed how we prevent sickle cell disease. They offer hope to couples at risk. We’ll see how these technologies help families with sickle cell disease.

Preimplantation Genetic Diagnosis (PGD)

Preimplantation Genetic Diagnosis (PGD) is used during IVF to find genetic disorders in embryos. It can spot sickle cell disease, letting couples choose healthy embryos. This has been a big help for families with sickle cell disease, giving them a chance to have kids without passing on the disease.

Key benefits of PGD include:

  • Early detection of genetic disorders
  • Selection of healthy embryos for implantation
  • Reduced risk of transmitting sickle cell disease to offspring

In Vitro Fertilization with PGD

In vitro fertilization (IVF) with PGD combines creating embryos with genetic testing. It lets couples conceive while lowering the risk of sickle cell disease. The process includes ovarian stimulation, egg retrieval, fertilization, and embryo transfer.

As noted by a fertility specialist,

“IVF with PGD is a powerful tool for families at risk of genetic diseases. It not only helps in selecting healthy embryos but also provides peace of mind for prospective parents.”

Procedure

Description

Ovarian Stimulation

Medication is used to stimulate the ovaries to produce multiple eggs.

Egg Retrieval

Eggs are retrieved through a minor surgical procedure.

Fertilization

Eggs are fertilized with sperm in the laboratory.

PGD

Embryos are tested for sickle cell disease.

Embryo Transfer

Healthy embryos are transferred to the uterus.

Success Rates and Considerations

IVF with PGD success depends on several factors. These include the woman’s age, egg and sperm quality, and the genetic condition being tested. While PGD lowers the risk of sickle cell disease, it’s not a 100% guarantee. Couples should know the emotional, physical, and financial challenges of this process.

Success rates for IVF with PGD can vary:

  • Women under 35 years old have higher success rates
  • The quality of eggs and sperm affects outcomes
  • Multiple cycles may be necessary

Technologies like PGD and IVF with PGD are changing how we prevent sickle cell disease. They give couples tools to make informed choices, reducing the disease’s incidence.

Multidisciplinary Care for High-Risk Pregnancies

Multidisciplinary care is key for managing sickle cell disease in pregnancy. A complete approach is needed to reduce risks and ensure the best outcomes for mom and baby.

The Healthcare Team

A team of healthcare experts is vital for SCD pregnancies. This team includes obstetricians, hematologists, and maternal-fetal medicine specialists. Effective communication among team members is essential to meet these complex needs.

For more information on managing sickle cell disease, you can refer to our detailed article on.

Specialized Monitoring During Pregnancy

Specialized monitoring is a critical part of care for pregnant women with SCD. Regular check-ups and assessments help spot complications early. Monitoring includes regular blood tests, ultrasounds, and other diagnostic tests as needed.

Birth Planning

Birth planning is a big part of managing high-risk pregnancies. We work with the patient to create a personalized birth plan. This plan covers their specific needs and concerns, including delivery mode, pain management, and postpartum care.

Management Strategies During Pregnancy

A good plan is key for pregnant women with sickle cell disease. It’s important to manage risks and ensure a healthy pregnancy for both mom and baby.

Hydration and Nutrition

Drinking enough water and eating right are key. Adequate hydration lowers the chance of sickle cell crises. Nutritional support meets the needs of mom and baby.

  • Drink plenty of water all day.
  • Eat a balanced diet full of important nutrients.
  • Stay away from too much caffeine and sugary drinks.

Infection Prevention

Women with sickle cell disease are more at risk for infections. These can lead to serious problems. Infection prevention measures include:

  • Getting all recommended vaccines.
  • Washing hands often.
  • Staying away from sick people.

Pain Management

Managing pain is very important for pregnant women with sickle cell disease. Pain crises can be tough during pregnancy. A good pain management plan is needed.

Management Approach

Description

Pharmacological Interventions

Using the right medicines to control pain.

Non-Pharmacological Interventions

Methods like relaxation, breathing exercises, and physical therapy.

Blood Transfusion Therapy

Blood transfusion therapy might be suggested for pregnant women with sickle cell disease. It can lower the risk of serious problems. Regular transfusions reduce the number of sickle-prone red blood cells.

With these strategies, healthcare providers can greatly improve outcomes for pregnant women with sickle cell disease.

Conclusion: Comprehensive Approach to Preventing Sickle Cell Complications

Preventing Sickle Cell Disease (SCD) complications needs a detailed plan. This includes preconception counseling, genetic testing, and care from many doctors. We talked about how knowing the genetic cause of SCD is key.

It’s also important to find couples at risk and give them special care during pregnancy. This way, we can lower the chance of SCD problems and help those with rare genetic disorders.

Preventing SCD complications is more than just treating it. It’s about education, genetic counseling, and supporting families. This whole approach helps a lot in reducing SCD-related issues and improving life for those affected.

With planning before pregnancy, genetic tests, and new reproductive tech, we help couples make smart choices. Also, having many doctors work together during pregnancy is key. This team effort is vital for managing SCD well.

By teaming up and using a detailed plan, we can really help prevent SCD complications. This makes a big difference in the lives of those with this condition.

FAQ

What is sickle cell disease and how is it inherited?

Sickle cell disease (SCD) is a genetic disorder that affects red blood cells. It’s inherited in an autosomal recessive pattern. This means a person needs two abnormal genes, one from each parent, to have the disease.

Is sickle cell anemia preventable?

SCD isn’t fully preventable. But, genetic counseling and screening can help. They can identify at-risk couples and give them the info they need to make choices about having children.

What are the risks associated with SCD during pregnancy?

Women with SCD face higher risks during pregnancy. These include increased mortality risk and pregnancy complications. They also risk vaso-occlusive crises, pre-eclampsia, and caesarean delivery.

The fetus is at risk too. It could be born preterm, have low birth weight, or face other health issues.

What is the role of genetic counseling in SCD?

Genetic counseling helps people understand SCD’s risks and implications. It’s key for at-risk couples to discuss their options and plan for a healthy pregnancy.

What genetic testing options are available for SCD?

There are several genetic testing options for SCD. These include carrier screening tests, prenatal diagnostic tests, and non-invasive prenatal testing. These tests can identify at-risk individuals and provide info on passing SCD to offspring.

Can advanced reproductive technologies help prevent SCD?

Yes, advanced reproductive technologies like preimplantation genetic diagnosis (PGD) and in vitro fertilization (IVF) with PGD can prevent SCD. They help identify and select embryos not affected by the disease.

What is the importance of preconception planning for couples at risk of SCD?

Preconception planning is vital for couples at risk of SCD. It lets them improve their health before pregnancy. They can also discuss medication and make informed reproductive choices.

How is SCD managed during pregnancy?

Managing SCD during pregnancy involves several strategies. These include staying hydrated and well-nourished, preventing infections, managing pain, and using blood transfusions when needed. A team of specialists is essential for monitoring and care.

What are the different sickle cell genotypes and their clinical significance?

The main sickle cell genotypes are AS (sickle cell trait) and SS (sickle cell anemia). Other genotypes include SC and Sβ-thalassemia. Knowing the genotype is important for understanding the disease’s impact and implications during pregnancy.

What is double heterozygosity in the context of SCD?

Double heterozygosity means having two different abnormal hemoglobin genes, like HbS and HbC. This can lead to a milder form of SCD. But, it can also pose risks during pregnancy.

How does SCD affect fetal and neonatal outcomes?

SCD can increase the risk of preterm birth and low birth weight. It can also lead to other health issues in newborns. Close monitoring and management during pregnancy can help reduce these risks.

References

World Health Organization (WHO). WHO issues first global guideline to improve pregnancy care for women with sickle cell disease. https://www.who.int/news/item/19-06-2025-who-issues-first-global-guideline-to-improve-pregnancy-care-for-women-with-sickle-cell-disease

Pan American Health Organization (PAHO). First global guideline released to improve pregnancy care for women with sickle cell disease. https://www.paho.org/en/news/19-6-2025-first-global-guideline-released-improve-pregnancy-care-women-sickle-cell-disease

National Center for Biotechnology Information (NCBI). Maternal and perinatal outcomes of sickle cell disease in pregnancy: A nationwide cohort study. https://pmc.ncbi.nlm.nih.gov/articles/PMC11985365/

Rare Disease and Orphan Drugs Journal. Managing pregnancy in women with sickle cell disease: A focus on physiopathology, risks, and multidisciplinary care. https://www.oaepublish.com/articles/rdodj.2024.40

National Center for Biotechnology Information (NCBI). The rise in travel-associated measles infections. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816286/

Trusted Worldwide
30
Years of
Experience
30 Years Badge

With patients from across the globe, we bring over three decades of medical

Prof. MD. Oral Nevruz Prof. MD. Oral Nevruz Hematology Overview and Definition
Patient Reviews
Reviews from 9,651
4,9

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Spec. MD. Sabri Özaslan

Spec. MD. Sabri Özaslan

MD. ESEDULLA AGAYEV

MD. ESEDULLA AGAYEV

Prof. MD. Ahmet Barış Durukan

Prof. MD. Ahmet Barış Durukan

MD. FİDAN QULU

MD. FİDAN QULU

Spec. MD. Mine Önal

Spec. MD. Mine Önal

Spec. MD. Nümuna Aliyeva

Spec. MD.  İRFAN QEHREMANOV

Spec. MD. İRFAN QEHREMANOV

Spec. MD. Doğa Sevinçok

Spec. MD. Doğa Sevinçok

MD. Şehla Asgarova

Op. MD. Coşkun Erçel

Op. MD. Coşkun Erçel

Prof. MD. Selçuk Güneş

Prof. MD. Selçuk Güneş

Prof. MD. Oğuz Cebesoy

Prof. MD. Oğuz Cebesoy

Your Comparison List (you must select at least 2 packages)